Repatha

Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients
Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients
Fierce Pharma
Sanofi
Amgen
PCSK9 inhibitors
diabetes
Regeneron
Praluent
Repatha
Flag link:
Insurers, doctors battle over new heart disease drugs
Insurers, doctors battle over new heart disease drugs
CNBC
insurers
cardiovascular disease
statins
PCSK9 inhibitors
Amgen
Regeneron
Sanofi
Repatha
Praluent
Flag link:
In cost debate, Amgen stands by Repatha's value
In cost debate, Amgen stands by Repatha's value
BioPharma Dive
Amgen
Repatha
drug pricing
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Flag link:
Amgen Remains A Standout Among Biotechs
Amgen Remains A Standout Among Biotechs
Forbes
Amgen
Repatha
biotech
Flag link:
Drugmakers face challenges marketing new heart drugs
Drugmakers face challenges marketing new heart drugs
Medical Marketing and Media
drug marketing
Amgen
Repatha
Novartis
Entresto
Ilaris
canakinumab
Merck
Anacetrapib
Flag link:
Amgen inks first money-back guarantee for Repatha
Amgen inks first money-back guarantee for Repatha
BioPharma Dive
Amgen
Repatha
insurers
Flag link:
[video]What's Next for Amgen's Repatha?
[video]What's Next for Amgen's Repatha?
Motley Fool
Amgen
Repatha
Flag link:
Lilly, Pfizer, et al. back Sanofi and Regeneron in PCSK9 patent appeal. AbbVie doesn't
Lilly, Pfizer, et al. back Sanofi and Regeneron in PCSK9 patent appeal. AbbVie doesn't
Fierce Pharma
Eli Lilly
Pfizer
Sanofi
AbbVie
Regeneron
patents
PCSK9 inhibitors
Repatha
Flag link:
Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor
Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor
Xtalks
Amgen
patients
PCSK9 inhibitors
Repatha
Flag link:
How This Company Is Taking on Amgen
How This Company Is Taking on Amgen
Motley Fool
Amgen
Medicines Company
Repatha
inclisiran
Flag link:
Why Amgen's Success Was a Big Disappointment
Why Amgen's Success Was a Big Disappointment
Motley Fool
Amgen
Repatha
heart attacks
stroke
Flag link:
Amgen Blew It…For Medicines Co., Esperion Too
Amgen Blew It…For Medicines Co., Esperion Too
Barron's
Amgen
Medicines Company
Esperion Therapeutics
Repatha
inclisiran
Flag link:
Express Scripts says Amgen data opens door to patients
Express Scripts says Amgen data opens door to patients
Yahoo/Reuters
Express Scripts
Amgen
Repatha
patients
Flag link:
CVS Health says Amgen data may increase eligible patients by millions
CVS Health says Amgen data may increase eligible patients by millions
Yahoo/Reuters
CVS Health
Amgen
Repatha
patients
Flag link:
Amgen Drug Prevents Heart Attacks, Not Deaths, Disappointing Experts
Amgen Drug Prevents Heart Attacks, Not Deaths, Disappointing Experts
Forbes
Amgen
Repatha
heart attacks
stroke
clinical trials
Flag link:
Heart attack while on Repatha? Amgen will give you your money back
Heart attack while on Repatha? Amgen will give you your money back
Endpoints
Repatha
Amgen
heart attack
drug pricing
Flag link:
Amgen cholesterol drug cuts heart attack, stroke risk more than 20 pct-study
Amgen cholesterol drug cuts heart attack, stroke risk more than 20 pct-study
Yahoo/Reuters
Amgen
Repatha
heart attack
stroke
LDL cholesterol
Flag link:
Data on heart benefits of Amgen drug is key to unlocking sales
Data on heart benefits of Amgen drug is key to unlocking sales
Yahoo/Reuters
Amgen
Repatha
heart disease
Flag link:
Amgen launches new Repatha DTC ad
Amgen launches new Repatha DTC ad
Medical Marketing and Media
Amgen
DTC advertising
drug ads
Repatha
Flag link:
Amgen: Clinical Trials Set Stage for Further Upside
Amgen: Clinical Trials Set Stage for Further Upside
TheStreet.com
Amgen
clinical trials
Repatha
Flag link: